Retinal Artery Occlusion: Knowledge and Challenge of “Retinal Stroke”

doi:10.3969/j.issn.1673-5765.2023.06.011

Abstract

Abstract: Retinal artery occlusion is the main cause of acute painless monocular vision loss, and its pathogenesis and risk factors are similar to ischemic stroke, so it is named as “retinal stroke”. However, as a special type of stroke, the clinical management of “retinal stroke” is still highly uncertain and controversial. This article reviewed the literatures on “retinal stroke”, and introduced the definition, department for medical treatment, recognition and evaluation, examination, treatment and secondary prevention of “retinal stroke”, in order to help clinicians better understand and standardize the diagnosis and treatment of retinal stroke.

Key words: Retinal artery occlusion; Retinal stroke; Ischemic stroke

摘要： 视网膜动脉阻塞是临床上导致急性无痛性单眼视力丧失的主要疾病，由于发病机制和危险因素与缺血性卒中相似，被视为“视网膜卒中”。但作为一种特殊类型的卒中，“视网膜卒中”的临床管理仍存在较高的不确定性和争议。本文对“视网膜卒中”的定义演变、就诊科室、识别和评估、检查、治疗和二级预防等方面进行综述，以期为临床医师全面认识和系统规范诊治“视网膜卒中”提供依据。

关键词: 视网膜动脉阻塞; 视网膜卒中; 缺血性卒中

LU Qingli, WU Songdi. Retinal Artery Occlusion: Knowledge and Challenge of “Retinal Stroke” [J]. Chinese Journal of Stroke, 2023, 18(06): 712-719.

逯青丽, 吴松笛. 视网膜动脉阻塞：“视网膜卒中”的认识与挑战[J]. 中国卒中杂志, 2023, 18(06): 712-719.

References

[1] BIOUSSE V，NAHAB F，NEWMAN N J. Management of acute retinal ischemia：follow the guidelines![J]. Ophthalmology，2018，125（10）：1597-1607.
[2] HAYREH S S. Acute retinal arterial occlusive disorders[J]. Prog Retin Eye Res，2011，30（5）：359-394.
[3] LEE K E，TSCHOE C，COFFMAN S A，et al. Management of acute central retinal artery occlusion，a“retinal stroke”：an institutional series and literature review[J/OL]. J Stroke Cerebrovasc Dis，2021，30（2）：105531[2022-07-15]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105531.
[4] SACCO R L，KASNER S E，BRODERICK J P，et al. An updated definition of stroke for the 21st century：a statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke，2013，44（7）：2064-2089.
[5] HOYER C，KAHLERT C，GUNEY R，et al. Central retinal artery occlusion as a neuro-ophthalmological emergency：the need to raise public awareness[J]. Eur J Neurol，2021，28（6）：2111-2114.
[6] ALBERS G W，CAPLAN L R，EASTON J D，et al. Transient ischemic attack-proposal for a new
definition[J]. N Engl J Med，2002，347（21）：1713-1716.
[7] EASTON J D，SAVER J L，ALBERS G W，et al. Definition and evaluation of transient ischemic attack：a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council；Council on Cardiovascular Surgery and Anesthesia；Council on Cardiovascular Radiology and Intervention；Council on Cardiovascular Nursing；and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists[J]. Stroke，2009，40（6）：2276-2293.
[8] MAC GRORY B，SCHRAG M，BIOUSSE V，et al. Management of central retinal artery occlusion：a scientific statement from the American Heart Association[J/OL]. Stroke，2021，52（6）：e282-e294[2022-07-15]. https://doi.org/10.1161/STR.0000000000000366.
[9] WANG Y J，LI Z X，GU H Q，et al. China stroke statistics 2019：a report from the National Center for Healthcare Quality Management in Neurological Diseases，China National Clinical Research Center for Neurological Diseases，the Chinese Stroke Association，National Center for Chronic and Non-communicable Disease Control and Prevention，Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations[J]. Stroke Vasc Neurol，2020，5（3）：211-239.
[10] DATTILO M，BIOUSSE V，NEWMAN N J. Update on the management of central retinal artery occlusion[J]. Neurol Clin，2017，35（1）：83-100.
[11] OLSEN T W，PULIDO J S，FOLK J C，et al. Retinal and ophthalmic artery occlusions preferred practice pattern®[J/OL]. Ophthalmology，2017，124（2）：P120-P143[2022-07-15]. https://doi.org/10.1016/j.ophtha.2016.09.024.
[12] YOUN T S，LAVIN P，PATRYLO M，et al. Current treatment of central retinal artery occlusion：a national survey[J]. J Neurol，2018，265（2）：330-335.
[13] 王浩，常永业，石慧君，等. 217例视网膜中央动脉阻塞中医证型及视力预后分析[J]. 中国中医眼科杂志，2020，30（9）：632-636.
[14] 王润生，吕沛霖，张娅萍，等. 以尿激酶静脉溶栓为主治疗视网膜中央动脉阻塞115例临床疗效观察[J]. 中华眼底病杂志，2012，28（5）：466-471.
[15] 杨柳，瞿远珍. 我国神经眼科专科医师培养及学科发展现状浅述[J]. 中国卒中杂志，2019，14（6）：630-632.
[16] MIR T A，ARHAM A Z，FANG W，et al. Acute vascular ischemic events in patients with central retinal artery occlusion in the United States：a nationwide study 2003-2014[J/OL]. Am J Ophthalmol，2019，200：179-186[2022-07-15]. https://doi.org/10.1016/j.ajo.2019.01.009.
[17] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治指南2010[J]. 中华神经科杂志，2010，43（2）：146-153.
[18] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志，2015，48（4）：246-257.
[19] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志，2018，51（9）：666-682.
[20] KOTHARI R U，PANCIOLI A，LIU T，et al. Cincinnati prehospital stroke scale：reproducibility and validity[J]. Ann Emerg Med，1999，33（4）：373-378.
[21] KIDWELL C S，SAVER J L，SCHUBERT G B，et al. Design and retrospective analysis of the Los Angeles prehospital stroke screen（LAPSS）[J]. Prehosp Emerg Care，1998，2（4）：267-273.
[22] KLEINDORFER D O，MILLER R，MOOMAW C J，et al. Designing a message for public education regarding stroke：does FAST capture enough stroke?[J]. Stroke，2007，38（10）：2864-2868.
[23] ZHAO J，LIU R. Stroke 1-2-0：a rapid response programme for stroke in China[J]. Lancet Neurol，2017，16（1）：27-28.
[24] AROOR S，SINGH R，GOLDSTEIN L B. BE-FAST（balance，eyes，face，arm，speech，time）：reducing the proportion of strokes missed using the FAST mnemonic[J]. Stroke，2017，48（2）：479-481.
[25] KASNER S E. Clinical interpretation and use of stroke scales[J]. Lancet Neurol，2006，5（7）：603-612.
[26] Scandinavian stroke study group. Multicenter trial of hemodilution in ischemic stroke-background and study protocol[J]. Stroke，1985，16（5）：885-890.
[27] HANTSON L，DE WEERDT W，DE KEYSER J，et al. The European stroke scale[J]. Stroke，1994，25（11）：2215-2219.
[28] VU H T，KEEFFE J E，MCCARTY C A，et al. Impact of unilateral and bilateral vision loss on quality of life[J]. Br J Ophthalmol，2005，89（3）：360-363.
[29] SCHRAG M，YOUN T，SCHINDLER J，et al. Intravenous fibrinolytic therapy in central retinal artery occlusion：a patient-level meta-analysis[J]. JAMA Neurol，2015，72（10）：1148-1154.
[30] POWERS W J，RABINSTEIN A A，ACKERSON T，et al. 2018 guidelines for the early management of patients with acute ischemic stroke：a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke，2018，49（3）：e46-e110[2022-07-15]. https://doi.org/10.1161/STR.0000000000000211.
[31] BERGE E，WHITELEY W，AUDEBERT H，et al. European Stroke Organisation（ESO）guidelines on intravenous thrombolysis for acute ischaemic stroke[J/OL]. Eur Stroke J，2021，6（1）：I-LXII[2022-07-15]. https://doi.org/10.1177/2396987321989865.
[32] TSIVGOULIS G，KATSANOS A H，MALHOTRA K，et al. Thrombolysis for acute ischemic stroke in the unwitnessed or extended therapeutic time window[J/OL]. Neurology，2020，94（12）：e1241-e1248[2022-07-15]. https://doi.org/10.1212/WNL.0000000000008904.
[33] SHARMA R A，DATTILO M，NEWMAN N J，et al. Treatment of nonarteritic acute central retinal artery occlusion[J]. Asia Pac J Ophthalmol（Phila），2018，7（4）：235-241.
[34] BIOUSSE V，CALVETTI O，BRUCE B B，et al. Thrombolysis for central retinal artery occlusion[J]. J Neuroophthalmol，2007，27（3）：215-230.
[35] HAYREH S S，ZIMMERMAN M B，KIMURA A，et al. Central retinal artery occlusion. Retinal survival time[J]. Exp Eye Res，2004，78（3）：723-736.
[36] DUMITRASCU O M，SHEN J F，KURLI M，et al. Is intravenous thrombolysis safe and effective in central retinal artery occlusion? A critically appraised topic[J]. Neurologist，2017，22（4）：153-156.
[37] MAC GRORY B，NACKENOFF A，POLI S，et al. Intravenous fibrinolysis for central retinal artery occlusion：a cohort study and updated patient-level meta-analysis[J]. Stroke，2020，51（7）：2018-2025.
[38] OCHAKOVSKI G A，WENZEL D A，SPITZER M S，et al. Retinal oedema in central retinal artery occlusion develops as a function of time[J/OL]. Acta Ophthalmol，2020，98（6）：e680-e684[2022-07-15]. https://doi.org/10.1111/aos.14375.
[39] WENZEL D A，KROMER R，POLI S，et al. Optical coherence tomography-based determination of ischaemia onset-the temporal dynamics of retinal thickness increase in acute central retinal artery occlusion[J/OL]. Acta Ophthalmol，2021，99（2）：e247-e252[2022-07-15]. https://doi.org/10.1111/aos.14563.
[40] MAC GRORY B，LAVIN P，KIRSHNER H，et al. Thrombolytic therapy for acute central retinal artery occlusion[J]. Stroke，2020，51（2）：687-695.
[41] PAGE P S，KHATTAR N K，WHITE A C，et al. Intra-arterial thrombolysis for acute central retinal artery occlusion：a systematic review and meta-analysis[J/OL]. Front Neurol，2018，9：76[2022-07-15]. https://doi.org/10.3389/fneur.2018.00076.
[42] PAGE P S，CAMBON A C，JAMES R F. Visual improvement after intra-arterial thrombolysis for central retinal artery occlusion does not correlate with time to treatment[J]. Interv Neurol，2016，5（3/4）：131-139.
[43] KO S J，SHIN I C，KIM D W，et al. Safety and efficacy of selective intra-arterial thrombolysis for central retinal artery occlusion[J]. Korean J Ophthalmol，2021，35（4）：261-271.
[44] 王润生，雷涛，王毅，等. 超选择性眼动脉及选择性颈内动脉溶栓治疗视网膜中央动脉阻塞的疗效观察[J]. 中华眼底病杂志，2014，30（5）：450-453.
[45] 中国卒中学会，中国卒中学会神经介入分会，中华预防医学会卒中预防与控制专业委员会介入学组. 替罗非班在动脉粥样硬化性脑血管疾病中的临床应用专家共识[J]. 中国卒中杂志，2019，14（10）：1034-1044.
[46] RUDKIN A K，LEE A W，CHEN C S. Ocular neovascularization following central retinal artery occlusion：prevalence and timing of onset[J]. Eur J Ophthalmol，2010，20（6）：1042-1046.